MIT study reveals non-invasive treatment holds promise for treating ‘chemo brain’

MIT study reveals non-invasive treatment holds promise for treating ‘chemo brain’

A study by MIT researchers demonstrates the potential of a non-invasive gamma treatment to mitigate “chemo brain,” a condition associated with cognitive impairments in cancer patients undergoing chemotherapy. Initially aimed to treat Alzheimer’s disease, this therapy uses light and sound at a 40-hertz frequency to stimulate brain waves. (Source: PharmaTimes)

Share the Post:

Related Posts

Stroke experts to test emerging nerve stimulation treatment

A new stroke therapy that delivers electrical pulses to the brain via a portable device will be tested in a pioneering trial to improve arm recovery after stroke. Led by researchers from Sheffield Teaching Hospitals NHS Foundation Trust and the University of Sheffield, this trial aims to determine if transcutaneous vagus nerve stimulation can enhance hand and arm strength during rehabilitation therapy for stroke survivors. (Source: PharmaTimes)

Read More

Blood test for early Alzheimer’s detection

Researchers funded by the NIH have developed a method to detect toxic Aβ oligomers in patients’ blood, showing potential for early detection of Alzheimer’s disease. Tested on nearly 400 human blood samples, this method offers a way to intervene before significant brain damage occurs, and could also be adapted to detect other neurodegenerative diseases like Parkinson’s. (Source: NIH)

Read More